24 /100
LOW RISK
Score updated May 30, 2026

PTHS — Pelthos Therapeutics Inc. Dilution Risk Tracker

Track PTHS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PTHS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
45
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for PTHS.
🔔 Track PTHS — Get forecast alerts →

💹 Market Data

Market Cap$92.00M
Shares Outstanding3.48M
Float1.47M
Cash$31.98M
Debt$52.93M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 94.9% shares (2025Q4 vs prior)
15 institutional holders · 901.8K shares
#1 Murchinson Ltd. 289.5K shares
#2 Ikarian Capital, LLC 255.8K shares
#3 BOOTHBAY FUND MANAGEMENT, LLC 80.7K shares
+ 12 more holders Sign up free to view →

📉 Short Interest

Short Interest31.0K
Days to Cover1.3
% of Float2.1%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track PTHS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PTHS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for PTHS
📊 PTHS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PTHS Signal Convergence & Dark Pool Activity — StonkWhisper 📄 PTHS Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.